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ABSTRACT  The  ability  of acetylcholine  (ACh)  to  inhibit  13-agonist  stimulated 
calcium  current  was  compared  to  its  ability  to  activate  the  inwardly  rectifying 
potassium current Ig(ACh) in frog atrial myocytes. As suggested by previous studies, 
ACh  inhibited  the  calcium  current  at  concentrations  (ECs0 =  8  nM)  significantly 
lower  than  those  required  for  the  activation  of IK(ACh) (ECs0--101  nM).  The 
pharmacological profiles of the two responses suggest that despite the differences in 
agonist sensitivity, both are mediated by the same (m~) type of muscarinic receptors. 
Intracellular application of GDPI3S,  an inhibitor of G  protein function, completely 
abolished  both  responses,  implying  that  both  actions  of ACh  are  coupled  to 
effectors  by  G  proteins.  In  contrast,  intracellular  application  of pertussis  toxin 
(PTX)  shifted  to  higher  concentrations  (ECs0 =  170  nM)  but  did  not  abolish 
inhibition  of the  calcium  current  by ACh  even  though  the  block  of the  IK(ACh) 
response was complete.  Increasingly large  PTX concentrations  and/or  prolonged 
PTX  treatments  revealed  a  limiting,  FTX-resistant  inhibitory  component  that 
appears to be mediated by a FFX-insensitive G protein distinct from that mediating 
IK(ACh)- For  the  FIX-sensitive components,  the  different  agonist  dependencies  of 
/K(ACh)  activation and calcium current inhibition may imply that different G proteins 
mediate each response although alternate possibilities involving the same G protein 
either  functionally  sequestered  and/or  differentially  affected  by interactions  with 
effectors, can not be ruled out. 
INTRODUCTION 
Acetylcholine  alters  cardiac  function  by acting  on  several  cellular  regulatory  path- 
ways.  For ion  channels,  the  most  prominent  of these  include  the  inhibition  of the 
L-type calcium  current  induced  by 13  adrenergic  agonists  and  the  activation  of the 
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inwardly rectifying potassium current, IKtACh).I Both of these effects are blocked by 
atropine and are therefore mediated by activation of muscarinic cholinergic receptors 
(Giles  and  Noble,  1976;  Breitwieser and  Szabo,  1985;  Fischmeister  and  HartzeU, 
1986; for recent reviews see Hartzell,  1988; Trautwein and Hescheler,  1990; Szabo 
and Otero,  1990).  In atria,  the two pathways coexist, whereas in ventricular tissues 
IK(ACh) tends to be less prominent or absent (Giles and Imaizumi,  1988). Note that in 
both tissues there is a small, agonist-independent calcium current that is not affected 
by ACh  (see Trautwein and  Hescheler,  1990;  Fischmeister and  HartzeU,  1986).  In 
order not to confuse this basal component with the L-type/Ca observed as a result of 
~3-adrenergic stimulation, we shall designate the latter as 13-/Ca. 
IKCACh)  is  coupled  to  muscarinic  receptors  via  the  guanine  nucleotide  binding 
protein  GK  that,  upon  activation  by  agonist  bound  receptor,  increases  the  open 
probability of the inwardly rectifying IKtACh) channel through a membrane delimited 
process (Breitwieser and  Szabo,  1985;  Pfaffinger, Martin,  Hunter,  Nathanson,  and 
HiUe,  1985;  Brown and  Birnbaumer,  1990).  f3-Ica results  from an  increased  open 
probability of Ca  2§  channels  by way  of a  complex process  involving  {3-adrenergic 
receptor dependent activation of adenylyl cyclase via the G  protein Gs,  leading  to 
activation  of the  cAMP  dependent  protein  kinase-A  and  phosphorylation  of the 
L-type Ca  2+ channel or associated protein (Tsien, Bean, Hess, Lansman, Nilius, and 
Nowycky,  1986;  Hecheler,  Kameyama,  and  Trautwein,  1986,  for  a  review,  see 
Trautwein and Hescheler, 1990). Muscarinic inhibition of 13-lca may affect any one or 
several  of these  steps.  Previous  work  suggests  that  a  significant  portion  of the 
inhibitory action  of ACh  is  on  adenylyl cyclase by way  of an  inhibitory G  protein 
(Breitwieser  and  Szabo,  1985;  Nakajima,  Wu,  Irasawa,  and  Giles,  1990;  Parsons, 
Lagrutta, White, and Hartzell, 1991). Other concomitant mechanisms, however, have 
not been ruled out (Fischmeister and Hartzell, 1987; Fischmeister and Shrier, 1989). 
The  objective of this  work was  to  examine  the  mechanisms  by which  muscarinic 
receptors modulate  different effectors under physiological circumstances using the 
whole-cell  patch  clamp  technique.  In  particular,  we  wanted  to  determine  if the 
actions  of ACh  on  IK(ACh) and  13-Ica  are  mediated  by the  same  type of muscarinic 
receptors, if this action is mediated exclusively via G  proteins and if so, whether or 
not the participating G proteins are identical. 
METHODS 
Solutions and Drugs 
The  composition  of the  solutions  given  below  is  in  millimolar.  Ca~+-free Ringer  for  the 
preparation of atrial myocytes: 110 NaC1, 5.4 KCI, 1.0 MgCI~, 10 HEPES, pH 7.2 adjusted with 
NaOH.  Dissociation  medium:  CaZ+-free Ringer  supplemented with  1.2  mg/ml  collagenase 
(Boehringer Mannheim Biochemicals, Indianapolis,  IN) and 0.08 mg/ml protease (Type XIV, 
Sigma Chemical Co., St. Louis, MO). Normal K  + Ringer solution: 90 NaC1, 2.5 KCI, 5 MgC12, 
I A functionally important hyperpolarization-activated muscarinic-inhibited cation current, observed 
in mammalian atrial myocytes (If), has also been reported to have a high, nanomolar sensitivity to 
ACh (DiFrancesco, Ducouret, and Robinson, 1989). A similar current exists in cells of the frog sinus 
venosus but not those of the atria (Bois and Lenfant, 1990). LI ET AL.  PTX Effects on Ic~ and lg(ACh)  943 
2.5  CaCI~,  5  x  10 -3 tetrodotoxin, 20  HEPES,  pH  7.4  adjusted with NaOH  (~9  raM).  Cs § 
Ringer: 20 CsCI,  85 NaCI, 2.0 MgCI2, 2.0 CaCI~, 5  x  10 -3 tetrodotoxin, 20 HEPES,  pH 7.4 
adjusted with NaOH. Normal internal solution for the patch pipette: 80 K-aspartate, 30 KCI, 
0.5 EGTA, 5.0 HEPES, 2.5 MgATP, 0.2 GTP, pH 7.4 adjusted with KOH. Cs + internal solution: 
120  CsC1, 0.5 EGTA, 5.0 HEPES,  2.5 MgATP, 0.2 GTP, pH 7.4 with KOH. For experiments 
with pertussis toxin, the internal solutions were supplemented with 50 p,M [3NAD. 
Pertussis toxin (PTX;  100-400 p,g/ml in PBS) and RR toxin (see below) were a gift from Dr. 
Erik Hewlett, University of Virginia, Charlottesville, VA. Shortly before use, VFX was activated 
for 15 min at 35~  in a solution containing 1.0 Na~ATP,  2.0 Na~EGTA, 0.5% wt/vol Lubrol PX, 
0.03% wt/vol bovine serum  albumin,  10 Tris,  20  dithiothreitol, pH  7.5  and  the  PTX  stock 
diluted twofold. The activated FIX was diluted with internal solution as necessary (usually to 4 
p,g/ml).  In  control  experiments  solutions  "activated"  without  PTX  and,  in  some  cases 
substituting a  mutant toxin (RR toxin) unable to ADP ribosylate G  proteins (Pizza, Covacci, 
Bartoloni, Perugini, Nencioni,  DeMagistris, Villa, Nucci, Manetti, Bugnoli, Giovannoni, Bar- 
bieri, Sato, and Rappuoli, 1989),  were used to ascertain that no effects are seen in the absence 
of ADP ribosylation. 
The  drugs  used  in  the experiments were  (-)  isoproterenol (Iso), acetylcholine, atropine, 
pirenzepine, forskolin, all from Sigma Chemical Co. Forskolin was prepared as a stock solution 
of 10 mM in anhydrous ethanol; isoproterenol solutions were prepared before each experiment 
from  a  stock  solution  (1  mM)  containing  1  mM  ascorbic  acid.  AF-DX  116  was  a  gift of 
Boehringer Ingelheim (Reims, France). 
Preparations 
Bullfrog  (Rana  catesbeiana)  atrial cells were  isolated as  described in  Breitwieser and  Szabo 
(1988).  Briefly, the frog was killed by decapitation and  pithing; the heart was removed and 
washed in, and then perfused at 30~  for 25 min with Ca~§  Ringer solution, which had 
been thoroughly oxygenated by bubbling with 100% O~. Subsequently, the heart was perfused 
for ~ 30 rain with dissociation medium. The atrium was removed and suspended in low calcium 
Ringer (Ca2+-free solution supplemented with  200  o,M CaCI2). The  tissue was stored in  the 
refrigerator (4~  for up to 2 d. Myocytes were obtained by gentle agitation of the tissue in the 
suspension medium. 
Sarcolemma was purified from bullfrog and beef heart according to the procedures of Otero 
and  Szabo (1988)  and Jones  (1988),  respectively. Specific activity of muscarinic cholinergic 
binding sites (measured as [3H] quinuclidinyl benzilate binding sites) in sarcolemmal prepara- 
tions were 6-7 pmol/mg (frog) and 3-4 pmol/mg (beef). Before ADP ribosylation, membranes 
(3.5-4.2 mg/ml) were diluted with one volume of DNAse I (2.5 p.g/ml) and Lubrol PX (0.1% 
wt/vol). Pertussis toxin (170 I~g/ml in PBS) was mixed with an equal volume of 100 mM glycine 
(pH 8.0 with NaOH), 40 mM DTY and 2% (wt/vol) BSA, and activated for 20 rain at 350C. In 
controls  the  toxin was  replaced by  PBS.  ADP-ribosylation of membranes  (17.5  and  21  Ixg 
protein for beef and frog, respectively) by activated toxin (0.6 p,g) was performed in a volume of 
60 p.l; the final composition of the assay mixture was:  10 mM thymidine,  1 mM ATP,  1 mM 
EDTA, 0.1  mM GTP, 20 mM Tris (pH 7.8 with HCI) and 5 ~M [32P]NAD (7,500 dpm/pmol). 
After 2 h at 220C the reaction was quenched with 120  p~l of ice-cold NAD 10 mM (pH 7.5 with 
Tris) and the samples were centrifuged in an Airfuge (Beckman Instruments, Fullerton, CA) at 
197,000 g  for 5 rain. Pellets were suspended in Laemmli's sample buffer and reduced with 5 
mM DTT for 1 h at 50~  followed by alkylation with 20 mM NEM for 15 rain at 220C. Samples 
were loaded on  10% SDS-polyacrylamide gels (16 ￿  14 cm) and electrophoresed according to 
Laemmli. The gels were stained with Coomassie Brilliant Blue to verify recoveries, dried and 
autoradiographed for 24-48 h. 944  THE JOURNAL OF GENERAL PHYSIOLOGY ￿9 VOLUME 104  ￿9 1994 
Experimental  Arrangements 
The  whole-cell recording  configuration  of the  tight-seal technique  (Hamill,  Marty,  Neher, 
Sakmann, and Sigworth,  1981)  was used. Cells were allowed to settle in a recording chamber 
and  superfused with extracellular solution.  Patch  pipettes were fabricated from  square bore 
borosilicate  glass  (Glass  Co.  of America,  Millville, NJ)  using  a  Flaming-Brown  P  80/PC 
electrode puller (Sutter Instruments Co., San Rafael, CA) and had resistances between 2 to 5 
Mr/when filled with standard intracellular solution. Membrane currents were measured using 
an Axopatch 200A current to voltage converter (Axon Instruments, Inc., Foster City, CA). Some 
experiments were performed using custom-built electronics described in Breitwieser and Szabo 
(1988). Ag/AgCI electrodes were used to establish electrical contact with pipette and bathing 
solutions. The signal from the current to voltage converter was filtered (5 KHz, 8 dB/octave 
Bessel), recorded  for  archival on  magnetic  media  and  digitized using  a  DSP-assisted data 
acquisition board (DAP 2400,  Microstar Laboratories, Bellevue, WA) with 12-bit precision at a 
rate of 1,000 samples/s and analyzed on-line using software integral to the DAP 2400. Voltage 
clamp command potentials were also generated by the DAP 2400.  Most data were obtained 
from  ionic currents  in  response  to  250-ms  depolarizing pulses  to  -5  mV  from  a  holding 
potential of -85  mV,  applied at a  rate of 0.67  Hz.  (standard protocol). Initial peak inward 
currents and steady state pulse-end currents (10 ms average) were calculated for each response. 
Calcium currents were calculated as peak inward minus  steady state current.  Muscarinic K  + 
currents were calculated as the change in the pulse-end steady state current after a  1.5-min 
exposure to extracellular ACh.  For some experiments 1K(ACh) was measured by clamping the 
membrane potential to  -35 mV and continuously monitoring the membrane current during 
exposure to extracellular ACh. 
Rapid changes of the extraceUular solution were obtained by placing the cell near the tube 
from  which  solution was  perfusing  the  recording  chamber  at  a  velocity of  ~5  cm/s  and 
switching between different solutions using a rotary valve. This arrangement allowed complete 
solution changes within 50 ms. Solutions were applied to the interior of the cell via the patch 
electrode that could be perfused during the experiment using the pressure injection method 
described elsewhere (Lapointe and Szabo, 1988). 
Mean  values  -+  SEM  are  given  in  the  text.  Curve  fitting  and  statistical analysis were 
performed using  the  computer  program  SigmaPlot (landel Scientific, San  Rafael,  CA).  All 
experiments were carried out at room temperature (21-23~ 
RESULTS 
Differential  Effects of ACh on Ica and IK(ach) in Atrial Myocytes 
A  review of previous  data  suggests  that  acetylcholine inhibits  I~-Ica  at  significantly 
lower concentrations than those required for eliciting IK(ACh) although direct compari- 
sons  on  the  same  preparation  and  under  identical  circumstances  are  usually  not 
available (but see Giles and Noble,  1976;  Nargeot, Gamier, and Rougier,  1981). We 
have  examined  this issue by determining the dose-effect relationships in frog atrial 
myocytes where both/K(ACh) and ~-Ica are present. 
The dose dependence OflK(ACh)was determined by measuring quasi steady state K + 
currents induced by  1.5 min. exposure to extracellular ACh using the voltage clamp 
pulse protocol described in Methods.  Care was  taken to separate successive agonist 
applications by at least 3  min so that the cell could recover from any desensitization 
of the  response  (Pappano  and  Mubagwa,  1991).  Under  these  conditions  the  dose 
dependence of IK(ACh) was independent of the order in which various ACh concentra- LI ET AL.  PTX Effects on/ca and IK(ACh)  945 
tions were applied. Typical traces are shown in Fig. 1 A as lines connecting individual 
IK(ACh) determinations  made  at  1.5-s  intervals.  Responses  normalized  to  the  effect 
elicited by 10 IzM ACh are plotted as a function of ACh concentration in Fig. 2 (filled 
squares). The  solid line was obtained by a  nonlinear fit of the Michaelis equation with 
the maximal response  set to unity yielding the half maximal agonist concentration 
EC50  =  101  nM. 
Corresponding  experiments  for  the  inhibition  of [~-Ica  were  carried  out  in  Cs + 
containing internal and external solutions in order to eliminate any interference from 
ACh  induced  K +  currents.  Isoproterenol  (Iso,  2  I~M) was  used  to  elicit a  maximal 
13-lca response.  After the current  stabilized, increasing concentrations  of ACh were 
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FIGURE  1.  Differential  agonist 
sensitivities of/K(ACh) and IB-lca. 
(A)  Muscarinic  potassium  cur- 
rents  were  measured  at  1.5-s 
intervals at the end  of 250-ms 
depolarizing pulses  to  -5  mV 
from  a  holding  potential  of 
-85 inV.  Representative traces 
of IK(ACh) are shown for the indi- 
cated  concentrations  of extra- 
cellularly  applied  ACh.  Note 
that  individual data points are 
joined.  (B)  Calcium  currents 
were measured as the peak in- 
ward current  during  a  250-ms 
depolarizations to -5 mV from 
a holding potential of -85 mV, 
and  plotted  as  a  function  of 
time.  13-Ica was  induced  by  2 
I~M isoproterenol and the mus- 
carinic  inhibition  of 13-1ca was 
assessed by applying ACh at the 
indicated concentrations in the 
presence  of  2  IxM  isoproter- 
enol. 
applied to assay the dose dependence of the muscarinic inhibition. Calcium currents 
were  measured  as the peak inward current relative to  the  current  measured  at the 
end of 250 ms depolarizations to -5  mV from a holding potential of -85  InV. These 
transients, obtained at 5.25-s intervals, were plotted as a function of time as shown in 
Fig.  1 B  for a  typical experiment. Note that at the lowest concentrations (near 1 nM) 
ACh  often produced  a  slight increase in  [3-lca, observed also in other  preparations 
(Fischmeister  and  Shrier,  1989),  but  not  in  the  absence  of  Iso.  Half  maximal 
inhibition  was  always  near  10  nM  ACh  and  was  independent  of  previous  ACh 
applications  provided  that  13-Ica  has  been  allowed  to  recover  fully.  The  dose 
dependence of the inhibitory response is shown in Fig. 2 as filled circles. The dashed 946  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9 VOLUME  104 ￿9  1994 
line is a  nonlinear fit of data to the Michaelis equation yielding a  maximal effect of 
99% and a half-maximal inhibitory concentration ECs0 =  8.0 nM. Clearly, even in the 
same  preparation  and  under  the  same  experimental  conditions,  ACh  is  about  an 
order of magnitude more potent in inhibiting 13-Ica than inducing IK(ACh). 
Identification of Receptor Types 
The  difference  in  the  potency  of ACh  for activation of IK(ACh) compared with  the 
inhibition  of f3-Ica raises the possibility that these muscarinic cholinergic effects are 
mediated via distinct receptor subtypes. This issue was addressed  by the use of the 
subtype  specific  antagonists  pirenzepine  and  AF-DX  116  (Nathanson,  1987).  For 
IK(ACh) the effects of these  antagonists were determined  from the magnitude  of the 
outward current at the end of a  1-min application of 1 p,M ACh plus antagonist at a 
holding potential of -35 mV. The responses were normalized to control (1  txM ACh 
alone), obtained at least 3 min preceding the test responses in order to minimize any 
effects of desensitization.  The results are shown in Fig.  3 A. The data were fitted to 
the Hill equation using nonlinear least squares procedure. With  the maximal effect 
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FIGURE 2.  Dose-effect relation- 
ships for the activation of 1K(ACh) 
and  the  inhibition  of 13-Ic~ by 
ACh. The solid lines were drawn 
to the Michaelis equation,  as dis- 
cussed in the text. 
set  to  100%,  this  procedure  yielded  values  of IC50  =  0.49  I~M  and  0.38  I~M  for 
pirenzepine and AF-DX 116 respectively, as well as a Hill coefficient nH=  1.0 in both 
cases. 
The relative effectiveness of the antagonists for relieving the muscarinic inhibition 
of 13-Ica was  assessed  by examining  the  magnitude  of 13-Ica that  reappeared  after 
application of increasing concentrations of the antagonist together with 1 IxM Iso and 
1 IxM ACh. The results of these experiments are shown in  Fig.  3 B. The data were 
fitted to the Hill equation with the maximal effect set to 100%. For pirenzepine, the 
best fitting parameters were ICs0  =  1.7  txM and nH=  1.7 while for AF-DX  116 the 
corresponding parameters were IC50 =  2.3  p,M and nH=  1.44. 
The AF-DX 116/pirenzepine ICs0 ratios are near unity,  1.3 and 0.74 for IK(ACh)  and 
13-Ica respectively, suggesting  that  similar or identical  muscarinic receptor subtypes 
mediate these responses. One can estimate antagonist dissociation constants (Ki(amago- 
nist))  using the relationship: 
Ki(antag.nist)  =  IC50(antagonist)/(1  +  [agonist]/ECs0(agonist)  ).  (1) LI ET AL.  PTX Effects on Ic~ and IK(ACh)  947 
Table  I.  compares  these  estimates to corresponding Ki's reported for a  number  of 
muscarinic receptor  subtypes.  2 In  contrast  to  mammalian  cardiac mACh  receptors 
(Hammer,  Giraldo, Schavi,  Monferini,  and  Ladinsky,  1986;  Buckley, Bonner,  Buck- 
ley, and Brann,  1989),  the bullfrog cardiac mACh receptor has high affinity for both 
pirenzepine  and  AF-DX  116,  in  a  manner  reminiscent  of  chick  heart  mACh 
receptors.  Moreover,  Table I  shows  a  particularly strong similarity between Ki's for 
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FIGURE 3.  Comparison of the 
effectiveness  of  the  subtype- 
specific muscarinic antagonists 
pirenzepine and AF-DX 116 in 
blocking  IK(ACh) and  relieving 
the inhibition of fl-lca.  (A) An- 
tagonist  at  the  indicated con- 
centrations were applied extra- 
cellularly together with  1  ~M 
4  ACh. The  degree of inhibition 
was calculated as the percent of 
IK(ACh) remaining  after  1  min 
applications of antagonist con- 
taining  solutions  relative  to 
the  corresponding  control  re- 
sponse  observed  with  ACh 
alone. Applications were  sepa- 
rated by at least 5-min periods 
of washout with normal Ringers 
solution  in  order  to  minimize 
possible effects  of desensitiza- 
4  tion.  Each  data  point  repre- 
sents averages of three to seven 
measurements. The Hill equation was fitted to the data (solid lines) as discussed in the text. For 
pirenzepine, ICs0 =  0.40  ~,M and nn  =  1. For AF-DX 116,  ICs0 =  0.38  ~,M and nH=  1. (B) 
[3-1c~ was generated by applying 1 p,M isoproterenol and  measured as in Fig.  1. Antagonist 
effectiveness was  assayed by sequential applications of 1  ~M  ACh  together with  antagonist 
(0.01, 0.1,  1,  10 ~M). Data are plotted as percent of 13-Ica inhibition relative to that produced 
by 1 ~,M ACh in the absence of antagonist. The data were fit to the Hill equation, as described 
in the text. For pirenzepine, IC50 =  1.7 ~,M and n n =  1.7. For AF-DX 116 IC50 =  2.3 ~,M and 
nH=  1.4. 
bullfrog atrial mACh receptors and the m2mACh receptor subtypes identified in chick 
heart (Tietje and Nathanson,  1991),  suggesting that both the inhibition of fl-lca and 
the  induction  of IK(ACh) are  mediated  by  muscarinic  receptors  similar  to  the  m 2 
subtype present in chick heart. 
2 Note that Eq.  1 is valid only if the dose-response curve for antagonist has a Hill coefficient of one. 
Thus, the KD,antagonist  values in Table I for [~-Ica  may only be approximate. 948  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9 VOLUME  104 ￿9  1994 
Differential Effects  of IntraceUularly Applied Pertussis  Toxin 
In an effort to distinguish  the mechanisms by which muscarinic cholinergic stimula- 
tion inhibits  13-Ica and produces IK(ACh), we have examined the influence of pertussis 
toxin  (trYX)  on  these  processes.  ~  inhibits  Go/Gi  type  G  proteins  by  ADP 
ribosylation of their c~ subunit (Hazeki and Ui,  1981). PTX was applied intracellularly 
for two reasons.  First,  extracellularly applied  PTX does not intoxicate frog myocytes 
unless  FIX  enters  the  cells  through  defects  in  the  cell  membrane  (Li  and  Szabo, 
unpublished  observations).  Second,  intracellularly  applied  PTX  acts  rapidly,  within 
minutes  of its  application.  For optimal  effects,  PTX  (usually 4  v,g/ml) was  preacti- 
vated  as  described  in  Methods.  The  time  course with which  PTX  inhibits  IK(ACh) is 
illustrated  in the upper trace of Fig. 4, which plots steady state currents measured at 
the end of 250-ms depolarizations  to  -5  mV from a  holding potential  of -85  mV. 
IK(ACh) produced  by  1  IxM  ACh  applied  at  5-min  intervals  is  seen  to  decrease  in 
TABLE  I 
Comparison of Inhibition Constants for AFoDX 116 and Pirenzepine 
System  AF-DX 116  Pirenzepine  Ratio 
nM  nM 
IK(ACh)*  35  45  0.77 
[~-Ic~*  18  13  1.3 
Cm2/CHO:  35  58  0.60 
Cm2/YI:  18  15  1.2 
Cm4/CHO**  199  55  3.6 
Cm4/Y1  ~  77  38  2.0 
Pm 1  t  2500  18  139 
Pm2w  730  660  1.1 
Pm3w  2300  180  13 
Rm4w  2300  120  19 
*Present study, Ki from Eq. 1. 
:Tietje and Nathanson, 1991. 
~Fukuda et al., 1989. 
amplitude and vanish after  10 min of intracellular FFX perfusion. The lower trace in 
Fig.  4  shows  Ica measured  and  plotted  as  in  Fig.  1.  Calcium  current  was  elicited 
following a  complete  PTX induced block of IK(ACh) by applying Iso (1  IxM),  at  ~  13 
min in this experiment.  In contrast with the total block of IK(ACh), PTX treatment did 
not eliminate  inhibition of [3-Ica by  1 IxM ACh. 
While  full  PTX  action,  defined  here  by  a  complete  loss  of muscarinic  IK(ACh) 
response, did not abolish muscarinic inhibition of [3-Ica, it altered markedly the dose 
dependence for agonist. A  typical instance of this is  shown in Fig.  5 where  the ACh 
dose  dependence  of  the  [3-Ica  inhibition  was  assayed  following  full  PTX  action. 
Rather  than  decreasing  [3-Ica,  the  inward  transients  slightly increased  following the 
application  of 10 and  100 nM ACh. Inhibition of/Ca becomes evident only at  1 and 
10 p~M ACh. This is in contrast with Fig.  1, where in the absence of PTX half maximal 
inhibition  of/Ca was seen for 8 nM ACh. LI ET AL. 
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FIGURE 4.  Differential  effects  of 
FIX treatment on the ability  of ACh 
to  induce  /K(ACh)  and  inhibit  13-1ca. 
IK(ACh) was  measured  at  the  end  of 
250-ms  depolarizations  to  -5  mV 
from a holding potential of -85 mV, 
while  /ca was  measured  as  the  peak 
inward  current  elicited  during  these 
same  depolarizations.  Data  are  plot- 
ted as a function of time (/K(ACh), upper 
trace; Ic~, lower trace).  Note that since 
/K(ACh)  transients  contaminate  the 
peak inward current,/ca was not plot- 
ted when a large/K(ACh)  was present. Activated FIX (4 I~g/ml) was included in the patch pipette. 
Intracellular dialysis began at t  =  0, the time at which the membrane under the patch pipette 
was  ruptured.  As  expected,  PTX  eliminated  IK(ACh) but  not  13-Ic~ as  shown by responses  to 
extracellular applications of 1 p,M ACh and  1 p,M Iso (horizontal  bars). 
The ACh concentration dependence of/Ca after maximal PTX treatment is shown 
in  Fig.  6.  Data from  three  to  seven experiments  of the  type  shown  in  Fig.  5  were 
averaged and plotted against the ACh concentration as filled triangles. The solid line 
was  obtained  by  a  nonlinear  curve  fitting  procedure  of  the  Michaelis  equation 
yielding maximal  inhibition  of 72%  and  a  half maximal  inhibitory  concentration of 
170  nM.  Note  that  the  dose-effect  relationship  of  the  PTX-resistant  muscarinic 
inhibition  of j3-Ica  is  not  affected  by  the  order  of ACh  addition  and/or  previous 
exposure  to  ACh,  provided  that  sufficient  time  is  allowed  for  recovery  between 
additions. As Fig. 6 indicates, the most significant effect of full PTX action is a shift of 
the  dose-effect  relationship  to  higher  ACh  concentrations;  a  secondary  effect  of 
reducing somewhat the maximal attainable  inhibition is also seen. 
We have considered the possibility that despite a complete inhibition of the IK(ACh) 
response by FIX, the remaining muscarinic inhibition of fl-Ica reflects an incomplete 
action  of  PTX  on  its  G  protein  substrates.  Thus,  we  have  increased  the  PTX 
concentration in the patch pipette and extended  the duration of the PTX treatment 
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FIGURE  5.  Concentration  de- 
Iso 2 ~  pendence of 13-Ic~ inhibition by 
1  10  ACh following trI'X treatment. 
0.1  __I-- 
0.01  ,  r  ACh (~)  The patch pipette  contained 4 
~g/ml FIX; intracellular dialy- 
sis  started when  the whole-cell 
~~  configuration  was  attained 
(t =  0).  K +  currents  were 
I)  blocked  by  using  Cs +  in  the 
internal and external solutions. 
//  ...........  13-1ca  was  measured  as  in  Fig. 
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FIGURE 6.  Effect of PTX  treatment 
on  the  ACh  concentration  depen- 
dence of the muscarinic inhibition of 
I~-Ic~.  Potassium  currents  were 
blocked  by  Cs  §  in  the  internal  and 
external  solutions.  (Filled circles) con- 
trol  inhibitory  response  obtained  in 
the absence  of PTX.  (Filled triangles) 
inhibitory responses following FIX (4 
p,g/ml in the patch pipette, at least  10 
min intracellular dialysis before appli- 
cation of 2 I~M Iso). Each value repre- 
sents the average of at least three data 
points. Solid lines are nonlinear least 
square fits of the Michaelis  equation. 
For the control response maximal in- 
hibition is 99% and ECs0 =  8 nM; for 
the  PTX  maximal  inhibition  is  72% 
and ECs0 =  170 nM. 
in  order  to  force  G  protein  ADP ribosylation  to  completion.  The  results  of these 
experiments  are  summarized  in  Table  II.  Extending  the  PTX  treatment  did  not 
abolish  the  inhibitory  response.  Rather,  the  muscarinic  block  of  [3-/r  remained 
unaltered  by further  PTX treatment,  suggesting  that this  fraction  of the  inhibitory 
response is not mediated by a  PTX-sensitive G  protein. 
Involvement  of G Proteins 
We have also considered the possibility that part of the inhibitory response (e.g., the 
PTX resistant part) is not mediated by a G  protein.  If this is the case then maneuvers 
that block G  protein function should reveal a residual inhibitory response. As we have 
shown previously, (Li, Otero, and Szabo, unpublished observations; see also Breitwie- 
ser  and  Szabo,  1988;  Pfaffinger  et  al.,  1985)  IKIACh) is  completely  blocked  by 
intracellular  application  of 1 mM GDPJ3S. We  have used  this  treatment  to block G 
protein  function  in  general.  In  the  experiment  shown  in  Fig.  7 B,  IK(ACh) was 
abolished by 6 rain of GDPf3S application in a manner reminiscent of PTX treatment. 
Forskolin (50  ~M) was applied  to stimulate/ca  and ACh (1  ~.M) was then applied  to 
test for residual inhibitory response. Fig. 7 B shows the lack of any inhibition Of/ca; in 
TABLE  II 
Inhibition  of lc~ by ACh aj%r Varying Extents of PTX Treatment 
PTX treatment  15-20 min  3ff40  min  50-60 min 
4  ~m/ml PTX  56.1%  60.0%  59.6% 
1 p,M ACh  +-23.3 (n =  3)  -+3.I (n =  2)  +-9.8 (n =  3) 
4  o,g/ml PTX  74.0%  --  -- 
l0 I.LM ACh  ---15.5 (n =  4) 
20  ~,g/ml Frx  70.1%  --  -- 
10  I~M ACh  +-5.0 (n =  6) LI  ET  AL. 
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FIGURE 7.  The  inhibitory  re- 
sponse  remaining  after  PTX 
treatment  is  mediated by a  G 
protein.  (,4) The  patch pipette 
was filled with normal internal 
solution and forskolin (50  ~M) 
was  applied to  activate lea-  As 
expected,  ACh  (1  ~M)  inhib- 
ited  this  response.  (B)  The 
patch  pipette  was  supple- 
mented with  1 mM  GDPJ3S to 
inhibit  G  protein  function,  as 
verified by a  loss of IK(ACh) re- 
sponse. Forskolin (FSK; 50 oLM) 
was applied to activate Ic~. ACh 
(1 o,M) had no inhibitory action 
under these conditions. 
fact,  one  observes  a  slight  enhancement  of  /Ca.  Note  that  in  the  absence  of 
intracellular GDP[3S  one  observes a  large inhibition of/Ca  (Fig.  7 A)  in  agreement 
with  previous  reports  (Hartzell  and  Fischmeister,  1987;  Fischmeister  and  Shrier, 
1989). The fact that intracellular GDPI3S completely abolishes the inhibitory response 
implies  that  both  the  FIX  sensitive  and  the  FIX  resistant  components  of  the 
muscarinic inhibition of 13-lca are mediated by G  proteins. 
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FIGURE 8.  Lack of muscarinic 
effects  on  the  recovery  from 
fl-adrenergic  activation.  Brief 
applications (5  s)  of isoproter- 
enol  (1  oLM) were  used  to  in- 
duce  J3-1ca. After  a  control 
response (first transient), a sec- 
ond  response  was  produced 
and ACh (1  IzM, horizontal bar) 
was  applied during the  decay- 
ing phase of the response. The 
time course  of the control de- 
cay was  fitted by  an  arbitrary 
function (the sum of two exponentials, as described in the text) and drawn as a solid line. The 
same function,  scaled by a  factor of 0.96, was drawn for the decaying phase of the  second 
transient, obtained in the presence of ACb. The close agreement of the data points with the 
solid line indicates that ACh has little effect on the rate of J3-/ca decay. 952  THE  JOURNAL  OF  GENERAL PHYSIOLOGY ￿9 VOLUME 104  ￿9 1994 
Lack of Muscarinic Effects on the Recovery from Beta-Adrenergic  Activation 
It  is  possible  that  part  of the  muscarinic  inhibition  of [3-Ica  does  not  result  from 
inhibition  of Ca  2§  channel  activation by 13-agonist  but  rather  an  enhanced  rate  of 
recovery  of  the  system  from  activation,  for  example  due  to  enhanced  cAMP 
degradation  and/or  increased  phosphoprotein  phosphatase  activity.  In  this  case 
application of ACh following a short pulse of Iso, when recovery is in progress, should 
accelerate  the  decay  of ~-Ica.  Fig.  8  shows  that  contrary  to  this  expectation,  the 
presence of ACh does not alter the decay of ~-Ica.  Inward Ca  2§  transients elicited by 
depolarizing pulses of -5  mV from a  holding potential of -85  mV were measured 
and plotted as in Fig.  1. The first response shows 13-Ica  induced by a 5-s application of 
1 IxM Iso. The decay of 13-Ica could be approximated by a  sum of two exponentials 
and a constant (solid line): 
I =  a0 +Otl e-t/*I +  or2  e-t/*2  (2) 
with ct0  =  -100 pA, cxl  =  -436 pA, "q  =  60 s, (x2 =  -121  pA and 'I"  2  =  936  s. The 
second response was also induced by a  5-s application of 1 o~M Iso, however,  1 ~M 
ACh was applied during the recovery phase (horizontal  bar).  The solid curve for the 
recovery phase was drawn  according to Eq.  2  using an offset ((x0) of -100  pA,  the 
same time constants as for the first response, but with amplitudes ~1 and ~2 reduced 
by  the  same  factor,  0.96.  The  curve  approximates  the  experimental  data  closely, 
indicating  that  the  time  course  of decay  of  13-Ica is  not  significantly  affected  by 
muscarinic stimulation. Note that the same results are obtained when ACh is applied 
before the control response or when ACh is applied immediately following Iso (data 
not  shown).  Together with  the  observation  of the  effects  of ACh  on  intracellular 
cAMP (Fischmeister and Hartzell,  1986;  see Trautwein and Hescheler,  1990),  these 
data suggest that ACh has little or no effect on the deactivation of 13-Ic~. Thus,  the 
PTX insensitive component of the muscarinic  [3-Ica inhibition can not be explained 
by agonist effects on deactivation processes. 
DISCUSSION 
Differential Agonist Sensitivities  of IK(ACh) and fl-Ica Inhibition 
The  muscarinic  potassium  current  IKIACh) can be  induced  in  sino-atrial,  atrial  and 
atrio-ventricular  tissues,  but  it  is  not  prominent  in  mammalian ventricle.  13-Ica is 
present in  both  atrial  and ventricular tissues,  but  it  has  a  larger amplitude  in  the 
ventricle. For these reasons IKIACU)  has been studied in atrial tissues and 13-lca mostly 
in ventricular tissues (Giles and Noble,  1976). Although not performed on the same 
preparation,  these  early  studies  nevertheless  tended  to  suggest  that  ACh  inhibits 
[3-Ica at concentrations significantly lower than those required to induce IK(ACh). Using 
the sucrose gap technique,  Nargeot et al. (1981) observed differential sensitivities in 
frog  atrial  trabeculae,  ECs0  of 80  nM  and  1  o.M  for  [3-/Ca  inhibition  and  IK(ACh), 
respectively.  Here  we  extended  these  considerations  to  isolated  bullfrog  atrial 
myocytes using the patch clamp technique. We find a half maximal inhibition of ~~ 
by ACh of 8 nM which is significantly lower than that required to induce IK(ACh), 101 LI ET AL.  PTX Effecls on/Ca and IK(ACh)  953 
nM. The dose dependence of both effects can be fitted by the Hill equation using a 
Hill coefficient of one. 
It is interesting to note that at nanomolar concentrations ACh appears to stimulate 
[3-Ica slightly but consistently (see Fig.  1 A), an effect that becomes more apparent 
following VFX treatment, see Fig. 5.  It is in fact possible that a rapidly developing, 
dose  dependent  potentiation  of  [3-Ica underlies  the  apparent  lag  seen  for  the 
inhibition  of [3-Ica  by  ACh.  Related  observations  have  been  reported  by  Gallo, 
Alloatti,  Eva,  Oberto,  and  Levi  (1993),  albeit  for  much  higher concentrations  of 
agonist. It is likely that the ACh-induced increase of [3-/Ca is responsible for the lack 
of inhibitory response seen at 1 nM ACh (Fig. 2; note that the data point falls below 
the dashed line). This phenomenon may also have physiological implications. 
Identity of Receptor Subtypes Mediating  I1r  and [3-Ica Inhibition 
We have addressed the possibility that Ik~ACh) and [3-/Ca respond to ACh differently 
because  they are mediated by different types of muscarinic receptors.  Mammalian 
receptor  subtypes have been  identified pharmacologically based  on  differences in 
ligand affinities; pirenzepine, a  preferential antagonist of ml receptors, and AF-DX 
116,  a  preferential antagonist of m2 receptors, have been particularly useful in this 
respect (Hammer et al.,  1986;  Buckley et al.,  1989).  We have used these antagonists 
in an attempt to differentiate and identify the receptors acting on IK(ACh) and [3-Ica in 
bullfrog. In the presence of 1 ~,M ACh the ICs0 for decreasing IK~ACh)  was 0.38  ~M 
and  0.49  ~M  respectively  for  AF-DX  116  and  pirenzepine.  For  the  relief  of 
ACh-induced block of [3-Ica the corresponding ICs0's were 2.3 ~M and  1.7 ~M, Fig. 
3. The relative antagonist potencies can be compared for these two actions of ACh by 
comparing AF-DX 116/pirenzepine ICs0 ratios which are 0.77 for IK~ACh)  and 1.3 for 
[3-/Ca. Considering  the  range  of corresponding  relative  potencies  for  the  various 
receptor subtypes, some listed in Table I, these ratios are rather similar, suggesting 
that muscarinic receptors mediating the stimulation of IKIACh) and the inhibition of 
[3-Ica are not distinguishable. 
It is also possible to estimate antagonist dissociation constants from the data of Fig. 
3 provided that one makes certain assumptions about the underlying processes. For 
the  simplest case,  that of competitive binding, Ki's may be calculated using Eq.  1. 
This was done for IK(ACh) and [3-Ica using ECs0'S for ACh in the absence of antagonist 
(Fig. 2). The results are shown in Table I, together with Ki's for selected muscarinic 
receptor subtypes. These are chick m2 receptors expressed in Chinese hamster ovary 
(Cm2/CHO);  chick m2 receptors  expressed  in mouse Y1  cells (Cm2/Y1);  chick m4 
receptors  expressed  in  Chinese  hamster  ovary  (Cm4/CHO);  chick  m4  receptors 
expressed in mouse Y1 cells (Cm4/Y1) (Tietje and Nathanson, 1991);  porcine ml, m2, 
and m3 receptors expressed in Xenopus oocytes (respectively Pml, Pm2 and Pm3) and 
rat m4 receptors expressed in Xenopus oocytes (Rm4) (Fukuda, Kubo, Maeda, Akiba, 
Hidaeki, Mishina, Higashida, Neher,  Marty, and Numa,  1989).  Considering Ki's for 
mammalian receptor subtypes, typical values of which are shown in the last four rows 
of Table  I,  and  corresponding  data for muscarinic effects on  IK(ACh) and  [3-/Ca in 
bullfrog atria (first two rows),  a lack of pharmacological similarity becomes apparent. 
For the mammalian receptor subtypes the AF-DX  116/pirenzepine Ki ratios are all 
much larger than unity except for Pm2. While this would suggest an mz-like character 954  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9 VOLUME  104  ￿9  1994 
for the frog atrial receptors, the magnitude of the individual Ki's are at least  10-fold 
larger.  In  contrast,  chick cardiac  receptors  (rows  4-6  in Table  I)  show  significant 
pharmacological  similarities  to  the  ones  detected  in  frog.  In  particular,  both  the 
AF-DX  116 Ki's and the AF-DX  116/pirenzepine affinity ratios observed for the frog 
are very similar to those seen for chick m2 receptors. These considerations suggest 
that the muscarinic receptors that mediate the effects of ACh on IK(AUh) and [3-Ica in 
bullfrog atria are similar to the chick m  2 receptor subtype. 
The  antagonist  dependence of the  muscarinic  inhibition  of [3-Ica appears  to be 
steeper than that OflK(ACh) (Fig. 3). While our data do not have sufficient resolution to 
yield statistically well defined Hill coefficients, these are nevertheless clearly different 
from  unity  for  the  data  of  Fig.  3 B.  This  apparent  cooperativity  may  reveal 
complexities in the system with respect to antagonist binding. An alternate possibility 
is  that at low concentrations, antagonists  have the  simultaneous  action of relieving 
inhibition  of [3-Ica and  inhibiting  the  small  enhancement of [3-Ica by ACh.  These 
effects may combine to give the appearance of a  steeper than linear concentration 
dependence. As we have not found a way to eliminate the small,  low concentration 
enhancement of [3-Ica by ACh, we can not rule out this possibility. 
Taken together, these data indicate that differences in receptor subtypes can not be 
invoked to explain the differential sensitivity of IK(ACh) and 13-Iua to ACh.  Note that 
AF-DX  116  blocks  completely  the  inhibition  of {3-Ic~ by  ACh,  implying  that  the 
response, including any trI'X insensitive component, is entirely mediated by musca- 
rinic, Cm2-1ike receptors. It should be noted, however, that certain complexities may 
exist  in  the  behavior  of the  system.  Thus,  for  example,  when  nanomolar  ACh 
concentrations are used,  pirenzepine is significantly less potent than AF-DX  116 in 
reversing the inhibitory effect of ACh  on 13-Ica (Hanf, Li,  Szabo, and  Fischmeister, 
1993). Further studies will be required to elucidate the basis of these complexities. 
Part of the Muscarinic  Inhibition of ~-Ica Is Not PTX Sensitive 
Full inhibition of IK(ACh) implies that GK is subject to inactivation by ADP ribosylation. 
In contrast, the muscarinic inhibition of G'/Ca was not abolished by PTX although the 
EC50 was  shifted  to  higher concentrations,  from  8  nM  to  170  nM  ACh.  It would 
appear,  therefore,  that  muscarinic  inhibition  of [~-Ica is  more  complex  than  the 
activation of IK(ACh). 
A possible reason for a PTX-resistant component is that in the frog Gi/Go  type G 
proteins  are  resistant  to  ADP  ribosylation.  It  has  been  reported,  in  fact,  that 
recombinant So from the toad Xenopus shows reduced PTX sensitivity when compared 
to  its  mammalian  counterparts  (Blitzer,  Omri,  DeVivo,  Carty,  Premont,  Codina, 
Birnbaumer, Cotecchia, Carron, Lefkowitz, Landau, and Iyengar, 1993). This conclu- 
sion was based on experiments where amphibian and mammalian ~o were translated 
in vitro using the rabbit reticulocyte system, and subsequently ADP-ribosylated in the 
presence  of presumably  mammalian  [3~. Because  these  experimental  conditions, 
tailored  to  ensure  efficient translation  and  modification  of mammalian  PTX  sub- 
strates,  are  not  necessarily optimal  for amphibian  PTX  substrates,  we  performed 
experiments to investigate whether ADP ribosylation of frog Go/Gi-type G proteins is 
normal and comparable to that seen in mammalian systems. Fig. 9 shows the labeling 
pattern routinely observed when frog cardiac plasma membranes are ADP-ribosylated LI ET AL.  PTX Effects on Ica and IK(ACh)  955 
with  pertussis  toxin;  results  obtained  with  beef  membranes  run  simultaneously 
through  the  procedure at  comparable protein concentrations  (21  i~g and  17.5  ~g 
respectively for frog and beef) are also shown. In frog cardiac sarcolemma, the bands 
that are specifically labeled by the toxin migrate with apparent molecular weights of 
39-42 kD, with the lower Mr band(s) being more intensely labeled. ADP ribosylation 
of beef membranes gives essentially the same result (lane 3). This indicates that the 
~-subunits  of Gi/Go  proteins  in  native  SL  membranes  from bullfrog  heart  are  as 
susceptible  to ADP-ribosylation by pertussis  toxin  as  those  present  in  mammalian 
heart  membranes.  These  data,  together with  the  observation  that  extended 
treatments well beyond the times and concentrations required for complete suppres- 
sion  of IK(ACh) could  not  affect  the  residual  muscarinic  [3-/Ca inhibitory  response, 
suggests a different molecular mechanism for the latter process. 
It  should be  noted that while  a  large body of evidence suggests  that G  proteins 
couple muscarinic inhibition of 13-Ica, primarily through inhibition of adenylyl cyclase 
(Breitwieser and  Szabo,  1985;  Fischmeister and  Shrier,  1989;  Pappano  and  Mub- 
agwa,  1991), it is nevertheless possible that other mechanisms, possibly not mediated 
by  G  proteins,  also  contribute  to  the  inhibitory  response.  Our  observation  that 
FIGURE 9.  ADP ribosylation  of G proteins 
by  PTX  in  cardiac  sarcolemma  from frog 
and  beef,  Autoradiogram  of an  SDS-poly- 
acrylamide  gel is shown. Labeling was per- 
formed in the presence (+) or absence  (-) 
of PTX.  Apparent  molecular  weights  are 
marked on the right of the figure. (Lanes 1 
and 2) Frog SL; (lanes 3 and 4) bovine SL. 
The  results  shown  are  representative  of 
three  experiments  with  beef  membranes 
and 14 experiments with frog membranes. 
intracellular GDPI3S completely eliminated the inhibitory effect of ACh,  even when 
the latter was applied at high concentrations suggests,  however, that the inhibitory 
response is mediated entirely by G protein(s). 
We  find  that  intracellular  GDP~S  eliminates  IK(ACh) and  the  muscarinic  [3-Ica 
inhibition with a  similar time course so that no residual muscarinic ~-Ica inhibition 
can be observed once the IKIACh) response vanishes (see Fig.  7 B). This observation 
tends to rule out the possibility that a degree of PTX treatment sufficient to eliminate 
IK~ACh) may leave a  residue of unreacted G  protein that,  because of a  strong affinity 
for the cyclase, may appear as a FIX-insensitive component. 
These considerations suggest that muscarinic inhibition of [3-Ica is mediated by at 
least two G  proteins, only one of which is  a  substrate for ADP ribosylation by PTX. 
Inhibition of adenylyl cyclase by a  PTX-insensitive G protein, Gz, has been reported 
previously (Wong, Conklin, and Bourne,  1992) and a  similar type of G protein may 
be  responsible  for  the  PTX  resistant  inhibition  of  ~-Ica  observed  here.  Further 
experiments  using  specific  G  protein  reagents  will  be  necessary  to  establish  the 
identity of the Fl~-insensitive G protein involved in the inhibitory process. 956  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9 VOLUME  104  ￿9  1994 
Possible Mechanisms 
The higher ACh sensitivity of the PTX-dependent [3-Ica inhibitory response relative 
to  that  of  K +  channel  opening  implies  significant  differences  in  these  signal 
transduction  pathways.  The  similarities  in antagonist  binding  profiles suggest  that 
the differences are not at the level of the receptor but rather at the level of the G 
protein/effector system. The most obvious possibility is that these two processes are 
mediated by different G proteins, that is GK is not identical to Gi. This must in fact be 
the case for that  portion of [~-Ica which is  not  sensitive to PTX. In neuronal cells, 
cyclase activity is inhibited by Go while the direct activation of a  K(ACh) channel is 
mediated by Gi3, that is to say GK and Gi are different G protein isoforms; this finding 
is consistent with the participation of two different G  proteins in the effects of ACh 
(see Birnbaumer,  1992). This hypothesis would also explain why desensitization to 
ACh occurs at a faster rate for the muscarinic activation of K + current than for the 
muscarinic inhibition of [3-Ica (Pappano and Mubagwa,  1991; Honjo, Kodoma, Zang, 
and Boyett, 1992). An alternative hypothesis, however, is that the same G protein is 
involved in  both  effects and  the  differences arise  by way  of interactions with  the 
effector either  directly through  the  formation of a  preexisting  G  protein-effector 
complex  or  through  differential  rates  of G  protein-effector  interactions  and/or 
effector-modified rates of G protein deactivation. Kinetic arguments and the lack of 
cross-talk in  agonist  binding  suggests  that,  at  least  in  some  specific cell types,  G 
proteins  are  segregated  into  functional  complexes  (Graeser  and  Neubig,  1993). 
Simple kinetic considerations suggest, however, that our results are also explained by 
a  signal  transduction  system  with  mobile  components,  provided  that  G  protein- 
effector interactions and G protein deactivation are allowed to be effector dependent. 
A mechanism of this type would require that inhibition of adenylyl cyclase be more 
effective and longer lasting than IK(ACh) activation. This may come about as a result of 
a lower affinity of activated G protein for the K + channel relative to cyclase and/or an 
increased deactivation rate for the G  protein-K  + channel complex. The later would 
imply that G protein deactivation may depend on G protein-effector interactions, as 
seen  in  other systems  (Arshavsky  and  Bownds,  1992;  Pages,  Deterre,  and  Pfister, 
1992; Wong et al.,  1992). 
Recent experiments  suggest  that IK(ACh) activation is  mediated  by G  protein  [~/ 
subunits  (Logothetis, Kurachi, Galper, Neer, and Clapham,  1987;  Murphy, Graber, 
Garrison, and Szabo,  1993; Wickman,  Iniguez-Lluhl, Davenport, Taussig,  Krapivin- 
sky,  Linder,  Gilman,  and  Clapham,  1994)  while  adenylyl  cyclase  inhibition  is 
produced both by G  protein a  and  13~ subunits  (Fang,  Iniguez-Lluhl, Mumby, and 
Gilman,  1992). A  mechanism  of this  type could explain  the  differences in  agonist 
sensitivities of IK(ACh) and  13-Ica without invoking a  second G  protein species which 
would  be  nevertheless required  in  order  to  take  into  account the  PTX-insensitive 
component we observe. Note, however, that since IK(ACh) activation seems to have no 
1~/specificity (Murphy et al.,  1993; Wickman et al.,  1994) the 13~/subunits  produced 
by activation of PTX insensitive G proteins would be expected to activate IK(ACh). That 
this is not seen tends to argue against the subunit hypothesis. 
During the preparation of this manuscript, nitric oxide has been reported to be an 
obligatory component of the  muscarinic  inhibition  of [3-Ica in  myocytes from  the LI El" AL.  PTX Effects on/ca and IKtACh)  957 
mammalian  sino-atrial  node  (Han,  Shimoni,  and  Giles,  1994).  While  we  have  no 
indication whether or not this mechanism  is present in frog atrial myocytes, our data 
suggests  that  if it  is  present  then  it  must  be  mediated  via  a  G  protein.  Further 
experiments will be required to determine examine  the relevance of this mechanism 
to our observations. 
We thank Dr. Erik L. Hewlett for providing us with toxins and Dr. Qing Ye for assistance with some 
experiments. 
This  work  was  partly  supported  by  NIH  Grant  HL37127  (G.  Szabo);  an  INSERM  France-USA 
exchange program  (G.  Szabo),  a  grant from  Bayer-Pharma  (R.  Hanf)  and  the  Fondation  pour la 
Recherche Medicale (R. Fischmeister). 
Original version received 18 May 1993 and accepted version received 22July 1994. 
REFERENCES 
Arshavsky, V. Y., and M. D. Bownds.  1992.  Regulation of deactivation of photoreceptor G-protein by 
its target enzyme and cGMP. Nature. 357:416-417. 
Birnbaumer, L. 1992.  Receptor-to-effector signaling through G proteins: roles for 13~, dimers as well 
as a  subunits.  Cell. 71:1069-1072. 
Blitzer, R. D., G. Omri, M. DeVivo, D.J. Carty, R. Premont, J. Codina, L. Birnbaumer, S. Cotecchia, 
M.  Caron,  R. J.  Lefkowitz, R.  E.  M.  Landau,  and  R.  Iyengar.  1993.  Coupling of the expressed 
~lb-adrenergic receptor to the phospholipase  C  pathway in Xenopus oocytes. Journal  of Biological 
Chemistry. 268:7532-7537. 
Bois,  P.,  and J.  Lenfant.  1990.  Isolated cells of the frog sinus  venosus:  properties  of the  inward 
current activated during hyperpolarization. PflCigers Archiv. 416:339-346. 
Brown, A. M., and L. Birnbaumer.  1990.  Ionic channels and their regulation by G protein subunits. 
Annual Review of Physiology. 52:197-213. 
Breitwieser, G. E., and G. Szabo. 1985.  Uncoupling of cardiac muscarinic and 13-adrenergic  receptors 
from ion channels by a guanine nucleotide analogue. Nature. 317:538-540. 
Breitwieser,  G.  E.,  and  G.  Szabo.  1988.  Mechanism  of muscarinic  receptor-induced  K +  channel 
activation as revealed by hydrolysis-resistant GTP analogues.Journal  of General Physiology. 91:469- 
493. 
Buckley, N.J., T. I. Bonner, C. M. Buckley, and M. R. Brann.  1989. Antagonist binding properties of 
five cloned muscarinic receptors expressed in CHO-K1 cells. Molecular Pharmacology. 35:469--476. 
DiFrancesco, D., P. Ducouret, and R. Robinson.  1989.  Muscarinic modulation of cardiac rate at low 
acetylcholine concentrations. Science. 243:669-671. 
Fischmeister, R., and H. C. Hartzell.  1986.  Mechanism of action of acetylcholine on calcium current 
in single cells from frog ventricle.Journal  of Physiology. 376:183-202. 
Fischmeister,  R.,  and  H.  C.  Hartzell.  1987.  Cyclic guanosine  3',5'-monophosphate  regulates  the 
calcium current in single cells from frog ventricle.Journal  of Physiology. 387:453-472. 
Fischmeister, R., and A. Shrier.  1989.  Interactive effects of isoproterenoi, forskolin and acetylcholine 
on Ca  2+ current in frog ventricular myocytes.Journal of Physiology. 417:213-239. 
Fukuda, K., T. Kubo, A. Maeda, I. Akiba, B. Hideaki, M. Mishina, H. Higashida, E. Neher, A. Marty, 
and  S.  Numa.  1989.  Selective effector coupling of muscarinic  acetylcholine receptor  subtypes. 
Trends in Pharmacological Sciences. 10:(Suppl):4-10. 
Gallo, M. P., G. Alloatti, C. Eva, A. Oberto, and R. C. Levi.  1993.  Ml muscarinic receptors increase 
calcium current  and  phosphoinositide  turnover in  guinea-pig ventricular cardiocytes. Journal  of 
Physiology. 471:41-60. 958  THE JOURNAL OF  GENERAL PHYSIOLOGY ￿9 VOLUME 104 ￿9 1994 
Giles, W.  R.,  and S. J. Noble.  1976. Changes in membrane currents in bullfrog atrium produced by 
acetylcholine. Journal of Physiology. 261:103-123. 
Giles,  W.  R.,  and  Y.  Imaizumi.  1988.  Comparison  of  potassium  currents  in  rabbit  atrial  and 
ventricular cells.Journal of Physiology. 405:123-145. 
Graeser,  D.,  and  R.  R.  Neubig.  1993.  Compartmentation  of receptors  and  guanine  nucleotide- 
binding proteins in NG108-15 cells: lack of cross-talk in agonist binding among the a9-adrenergic, 
muscarinic, and opiate receptors. Molecular Pharmacology. 44:434-443. 
Hanf,  R.,  Y.  Li,  G.  Szabo,  and  R.  Fischmeister.  1993.  Agonist-independent effects of muscarinic 
antagonists on Ca  2+ and K + currents in frog and rat cardiac cells.Journal of Physiology. 461:743- 
765. 
Hamill,  O.  P.,  A.  Marty,  E.  Neher,  B.  Sakmann,  and  F.  Sigworth.  1981.  Improved  patch-clamp 
techniques  for  high-resolution  current  recording  from  cells  and  cell-free  membrane  patches. 
Pflagers Archiv. 391:85-100. 
Hammer,  R.,  E.  Giraido,  E.  Schiavi, G.  B.  Monferini, and A.  Ladinsky.  1986.  Binding profile of a 
novel cardioselective  muscarine  receptor  antagonist,  AF-DX  116,  to  membranes  of peripheral 
tissues and brain in the rat. Life Sciences. 38:1653-1662. 
Han, X., Y. Shimoni, and W. R. Giles.  1994. An obligatory role for nitric oxide in autonomic control 
of mammalian heart rate. Journal of Physiology. 476:309-314. 
Hartzell, H. C.  1988.  Regulation of cardiac ion channels by catecholamines, acetylcholine and 2nd 
messenger systems. Progress in Biophysics and Molecular Biology. 52:165-247. 
Hartzell, H. C., and R. Fischmeister. 1987. Effect of forskolin and acetylcholine on calcium current in 
single isolated cardiac myocytes. Molecular Pharmacology. 32:639-645. 
Hazeki, O., and M. Ui.  1981. Modification by islet activating protein of receptor mediated regulation 
of cyclic  AMP accumulation in isolated rat heart cells. Journal of Biological Chemistry. 256:2856- 
2862. 
Hescheler, J., M. Kameyama, and W. Trautwein.  1986. On the mechanism of muscarinic inhibition of 
the cardiac Ca  2+ current. Pflagers Archiv. 407:182-189. 
Honjo, H., I. Kodoma, W.J. Zang, and M. R. Boyett.  1992. Desensitization to acetylcholine in single 
sino-atrial node cells isolated from the rabbit heart. American Journal of Physiology. 263:H1779- 
1789. 
Jones,  L.  R.  1988.  Rapid preparation  of canine cardiac  sarcolemmai vesicles by sucrose flotation. 
Methods in Enzymology. 157:85-91. 
Lapointe, J.-Y.,  and  G.  Szabo.  1987.  A  novel  holder  allowing internal  perfusion  of patch-clamp 
pipettes. Pfliigers Archiv. 41:212-216. 
Li,  Y.,  A.  Otero,  R.  Hanf,  R.  Fischmeister, and G.  Szabo.  1992.  Different sensitivities to  pertussis 
toxin of muscarinic activation of IK~ACh/and inhibition of/ca in cardiac myocytes. Biophysical  Journal. 
61:145a (Abstr.) 
Logothetis,  D.  E.,  Y.  Kurachi, J.  Galper,  E.  Neer,  and  D.  E.  Clapham.  1987.  The  13~/ subunits of 
GTP-binding proteins activate the muscarinic K + channel in heart. Nature. 325:321-326. 
Murphy, J.  F.,  S. Graber, J.  C.  Garrison, and G. Szabo.  1993. Recombinant G  protein 13"r subunits 
activate the muscarinic K + channel in bullfrog atrial myocytes. FASEBJournal. 7:A1138. (Abstr.) 
Nakajima, T., S. Wu, H. Irisawa, and W. Giles.  1990. Mechanism of acetylcholine-induced inhibition 
of Ca  2+ current in bullfrog atrial myocytes. Journal of General Physiology. 96:865-885. 
Nargeot, J.,  D. Garnier, and O.  Rougier.  1981. Analysis of the inotropic effect of acetylcholine on 
frog atrial fibres.Journal of Physiology. 77:829-843. 
Nathanson, N. M.  1987. Molecular properties of the muscarinic acetylcholine receptor.  1987. Annual 
Review of Neuroscience. 10:195-236. Li ET AL.  PTX Effects on lea and IK(ACh)  959 
Otero, A.  S.,  and  G.  Szabo.  1988.  Role of the  sodium pump  and  the background  K + channel  in 
passive  K +  (Rb +)  uptake  by  isolated  cardiac  sarcolemmal vesicles. Journal  of Membrane  Biology. 
104:253-263. 
Pages, F., P.  Deterre, and C. Pfister.  1992.  Enhanced GTPase activity of transducin when bound to 
cGMP phosphodiesterase  in bovine retinal rods. Journal of Biological  Chemistry. 267:22018-22021. 
Pappano,  A.  J.,  and  K.  Mubagwa.  1991.  Muscarinic  agonist-induced  actions  on  potassium  and 
calcium channels in atrial myocytes: differential desensitization. European  Heart Journal.  12(Suppl. 
F):70-75. 
Parsons, T. D., A. Lagrutta, R. E. White, and H. C. Hartzell. 1991.  Regulation of Ca  2+ current in frog 
ventricular cardiomyocytes by 5'-guanylylimidodiphosphate and acetylcholine.Journal  of Physiology. 
432:593-620. 
Pizza,  M., A. Covacci, A. Bartoloni, M. Perugini, L. Nencioni, M. DeMagistris, L. Villa, D. Nucci, R. 
Manetti,  M.  Buguoli, F.  Giovannoni, J. Olivieri, J. T.  Barbieri,  H.  Sato,  and  R.  Rappuoli.  1989. 
Mutants of pertussis toxin suitable for vaccine development. Science. 246:497-500. 
Pfaffinger, P. J., J.  M.  Martin,  D.  D.  Hunter,  N.  M.  Nathanson,  and  B.  Hille.  1985.  GTP binding 
proteins couple cardiac muscarinic receptors to a K channel. Nature.  317:536-538. 
Szabo, G., and A. S. Otero.  1990.  G  protein-mediated  regulation of K + channels  in heart. Annual 
Review of Physiology. 52:293-305. 
Tang,  W. J., J.  A.  Iniguez-Lluhi,  S.  Mumby,  and  A.  G.  Gilman.  1992.  Regulation of mammalian 
adenylyl cyclases  by  G-protein  ct  and  [~  subunits.  Cold  Spring  Harbor  Symposia  on  Quantitative 
Biology. 57:135-144. 
Tietje,  K.  M.,  and  N.  M.  Nathanson.  1991.  Embrionic chick heart  expresses  multiple muscarinic 
acetylcoline receptor subtypes. Journal of Biological Chemistry. 266:17382-17387. 
Trautwein, W., and J. Hescheler.  1990.  Regulation of cardiac L-type calcium current by phosphory- 
lation and G proteins. Annual Review of Physiology. 52:257-274. 
Tsien, R. W., B. P. Bean, P. Hess, J. B. Lansman, B. Nilius, and M. C. Nowycky.  1986.  Mechanisms of 
calcium channel modulation by [3-adrenergic agents and dihydropyridine calcium agonists.Journal 
of Molecular  and Cellular Cardiology.  18:691-710. 
Wickman,  K. D., J. A. Iniguez-Lluhl, P. A. Davenport, R. Taussig, G. B. Krapivinsky, M. E. Linder, 
A. G. Gilman, and D. E. Clapham.  1994.  Recombinant G-protein beta gamma-subunits activate the 
muscarinic-gated atrial potassium channel. Nature.  368:255-257. 
Wong, Y. H., B. R. Conklin, and H. R. Bourne.  1992. Gz-mediated hormonal inhibition of cyclic AMP 
accumulation. Science. 255:339-342. 